Nephrolithiasis is one of the most common conditions affecting the kidney and is characterized by a high risk of recurrence. Thiazide diuretic agents are widely used for prevention of the ...

Medindia neither buys nor sells drugs. Hydrochlorothiazide (Hydrazide (25 mg)) is a thiazide diuretic, prescribed for high blood pressure (hypertension) and edema.It helps the kidneys to remove ...

The mean age was 72 years. At baseline, hydrochlorothiazide at a dose of 25 mg per day had been prescribed in 12,781 patients (94.5%). The mean baseline systolic blood pressure in each group was ...

The rate of radiologic recurrence was significantly lower in the 25- and 50-mg hydrochlorothiazide groups compared with the placebo group: 32% and 34% vs 49%, respectively. At baseline ...

May 14 (Reuters) - The U.S. Food & Drug Administration has extended its review of Ascendis Pharma's (A71.F), opens new tab therapy to treat adult patients with a hormone disorder by three months ...

May 1 (Reuters) - Denmark-based Ascendis Pharma A/S A71.F said on Monday the U.S. Food & Drug Administration had declined to approve its experimental therapy to treat adult patients with a hormone ...

Ascendis Pharma noted that the FDA approved Skytrofa or lonapegsomatropin-tcgd for the treatment of pediatric patients one year and older who weigh at least 11.5 kg (25.4 lb) and have growth ...

(Adds share movement in paragraph 2, CEO quote in paragraph 7, background in paragraphs 8 to 12) May 14 (Reuters) - The U.S. Food & Drug Administration has extended its review of Ascendis Pharma's ...